Researchers believe that the development of GzmA inhibitors for the treatment of RA may have beneficial effects compared to other commonly used anti-inflammatory drugs, such as corticosteroids or TNF blockers (37). This evidence concerns the gene GZMA and rheumatoid arthritis.